Regulatory flexibility can make continuous improvement possible.
Lois Atkins
Advertisement
Lois Atkins is a principal consultant, CMC regulatory affairs at Eli Lilly and Company
Articles by Lois Atkins
First in a three-part series that discusses the complexities of QbD implementation in biotech product development.
Advertisement
Latest Updated Articles
Quality by Design for Biotechnology Products—Part 3January 1st 2010
Quality by Design for Biotechnology Products—Part 1November 1st 2009
Advertisement
Advertisement